1. Impact of alirocumab added to high-intensity statin therapy on platelet function in AMI patients: a pre-specified substudy of the randomized, placebo-controlled PACMAN-AMI trial. (3rd October 2022) Authors: Ueki, Y; Haner, J; Losdat, S; Gargiulo, G; Bar, S; Otsuka, T; Kavaliauskaite, R; Mitter, V; Temperli, F; Shibutani, H; Siontis, G; Valgimigli, M; Windecker, S; Koskinas, K; Raber, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: a sub-study of the randomized placebo-controlled PACMAN-AMI trial. (3rd October 2022) Authors: Rexhaj, E; Soria, R; Baer, S; Kavaliauskaite, R; Yasushi, U; Tatsuhiko, O; Temperli, F; Shibutani, H; Siontis Cm, G; Haener D, J; Stortecky, S; Windecker, S; Koskinas C, K; Losdat, S; Raeber, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗